Clinical Trial Update: Pembrolizumab Combination With Lenvatinib in Pts With Recurrent,Persistent,Metastatic or Locally Advanced Vulvar Cancer Not Amenable to Curative Surgery or Radiotherapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating pembrolizumab in combination with lenvatinib for recurrent, persistent, metastatic, or locally advanced vulvar cancer; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvar Cancer

Drugs mentioned

• Lenvatinib (Lenvima) (lenvatinib)
• Pembrolizumab (Keytruda) (pembrolizumab)

Snippet

Sponsor: AGO Research GmbH | Conditions: Recurrent Vulvar Cancer, Persistent Vulvar Cancer | Phase 2 | Status: RECRUITING